The Sub-$250M Analyst Coverage Problem Nobody Talks About

Only 5% of sub-$250M issuers have any analyst coverage at all. Let that number sit for a moment.

That means 95% of companies in that market cap range are invisible to institutional investors who rely on research to make allocation decisions. They can't find you on the screen. They can't read a model on your business. They have no independent validation of your investment thesis.

This is not a problem you can solve after you list. The window for engaging analysts — particularly at the sell-side — opens in the months before your listing and closes quickly after. Most companies miss it entirely because they're focused on the transaction itself, not on what happens the day after the transaction closes.

The structural reality of the sub-$250M market is that the IR system is tilted against the issuer. Bulge-bracket analysts don't cover you. Institutional investors have limited bandwidth to do their own work on small issuers. And without coverage, you're dependent on retail flow and momentum trading — neither of which builds a stable, long-term shareholder base.

The companies that solve this problem do it in advance. They identify the two or three boutique analysts who cover their sector, they build relationships before the roadshow, and they give those analysts the access and materials they need to initiate coverage on or shortly after listing day.

This is not something a banker manages for you. A banker's job ends at the close. The analyst coverage strategy — and the relationships required to execute it — has to be built by someone who will still be in the room after the listing event. That's the work we do.